Top 5 Medical Device VC Deals, H1 2010
A simplified diabetes device, two eye treatments, a surgical back device, and diagnostic biomarkers--these five technologies attracted the most venture capital funding in the first half of 2010. At the halfway point, Intuity Medical and its all-in-one glucose monitoring system gained the most funding.
In the second quarter, the industry landed $755 million on 95 deals, up 40 percent from the first quarter, according to PriceWaterhouseCoopers. Overall in the first half, medical device makers drew in $1.272 billion in 156 device deals. Report >>
1. Intuity Medical - $64M
2. TearScience - $44.5M
3. Aquesys - $35M
4. Baxano - $30M
5. Astute Medical - $26.5M
More stories about medical device venture capital
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: